RE-BVS – Piemonte Repository

Sfoglia per AUTORE
TODISCO E
Collezione AO Cuneo

Items : 6

AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia. in Cancer / Cancer. 2023 Apr 1;129(7):992-1004. doi: 10.1002/cncr.34608. Epub 2023 Jan 24.

2023
AOU Città della Salute di Torino
AO Cuneo
AO Ordine Mauriziano
AOU Novara

Martinelli G; Rossi G; Tarella C; Sciumè M; Marconi G; Abruzzese E; Cascavilla N; Rivellini F; Volpi R; Federico V; Gigli F; Roncoroni E; Romano A; Cardinali V; Nanni J; Maurillo L; Ferrara F; Lanza F; Cilloni D; Fianchi L; Lunghi M; Martini V; Molteni A; Gottardi M; Salutari P; Cairoli R; Borlenghi E; Manfra I; Basilico CM; et alii...

Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06. in Haematologica / Haematologica. 2021 Oct 1;106(10):2578-2587. doi: 10.3324/haematol.2020.252825.

2021
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Rambaldi A; Spinelli O; Bassan R; Pavoni C; Falini B; Cortelezzi A; Todisco E; Mattei D; Corradini P; Ciceri F; Bernardi M; Campiotti L; Scattolin AM; Tajana M; Borlenghi E; Cavattoni I; Cattaneo C; Terruzzi E; De Paoli L; Audisio E; Ferrero D; Mannelli F; Gianfaldoni G; Intermesoli T; Grassi A; Oldani E; Delaini F; Elidi L; Zanghi' P; et alii...

High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG). in Cancers / Cancers (Basel). 2020 Aug 11;12(8):2242. doi: 10.3390/cancers12082242.

2020
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria

Rambaldi A; Spinelli O; Fracchiolla N; Corradini P; Campiotti L; Tajana M; Todisco E; Ciceri F; Scattolin A; Mattei D; Cavattoni I; Borlenghi E; De Paoli L; Audisio E; Terruzzi E; Intermesoli T; Gianfaldoni G; Caprioli C; Stefanoni P; Oldani E; Lussana F; Elidi L; Buklijas K; Pavoni C; Michelato A; Cavagna R; Zanghì P; Salmoiraghi S; Bassan R; et alii...

Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML. in Blood advances / Blood Adv. 2019 Apr 9;3(7):1103-1117. doi: 10.1182/bloodadvances.2018026625.

2019
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Falini B; Pogliani EM; Rambaldi A; Audisio E; Bosi A; Cortelazzo S; Spinelli O; Oldani E; Zanghì P; Campiotti L; Corradini P; Cortelezzi A; Ferrero D; Todisco E; Bernardi M; Scattolin AM; De Paoli L; Cattaneo C; Borlenghi E; Ciceri F; Mattei D; Terruzzi E; Cavattoni I; Marmont F; Boschini C; Gianfaldoni G; Masciulli A; Pavoni C; Bassan R; et alii...

Molecular prolife by next generation sequencing of acute myeloid leukemia with normal karyotype: Clinical results from the prospective trial 02/06 of the Northern Italy leukemia group (NILG) in Haematologica

2018
AO Cuneo
AOU Alessandria

Spinelli O; Salmoiraghi S; Zanghi P; Cavagna R; Michelato A; Buklijas K; Zannino L; Intermesoli T; Lussana F; Delaini F; Oldani E; Caprioli C; Stefanoni P; Gianfaldoni G; Marmont F; Ferrero D; Terruzzi E; De Paoli L; Rossi G; Borlenghi E; Cavattoni I; Tajana M; Scattolin AM; Mattei D; Corradini P; Campiotti L; Ciceri F; Bernardi M; Todisco E; et alii...

Sequential high-dose cytarabine plus idarubicin improves remission rate and survival duration in adult acute myelogenous leukemia (AML): Randomized trial of the Northern Italy leukemia group (NILG) in Haematologica

2016
AOU Alessandria
AO Ordine Mauriziano
AO Cuneo

Bassan R; Intermesoli T; Masciulli A; Boschini C; Gianfaldoni G; Marmont F; Cavattoni I; Mattei D; Terruzzi E; De Paoli L; Rossi G; Borlenghi E; Ciceri F; Bernardi M; Scattolin AM; Todisco E; Campiotti L; Corradini P; Cortelezzi A; Tajana M; Ferrero D; Cignetti A; Marfisi RM; Delaini F; Zanghì P; Oldani E; Spinelli O; Audisio E; Cortelazzo S; et alii...